ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Rhythm Pharmaceuticals
A Director, Value & Evidence at Rhythm focuses on generating high-quality evidence to maximize the value proposition of their assets for rare neuroendocrine diseases. The role involves leading studies on patient-reported outcomes, real-world evidence generation, and health economics, while collaborating across teams to support decision making and access.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
Right around the average for this role
HTA, Value & Evidence Senior Manager
Pfizer
Lead Value Evidence, MA-US
Astellas
Director, Global Health Economics and Outcomes (GHEOR) - Immunology
Bristol Myers Squibb
HV&E Senior Manager
Pfizer
Senior Manager, HTA, Value and Evidence (HV&E), Rare Disease
Pfizer
Director, HTA, Value & Evidence (HV&E) – Obesity
Pfizer